muromonab-cd3
Showing 1 - 5 of 5
GVHD, Leukemia, MDS Trial in Seattle (biological, drug, genetic, other, procedure, radiation)
Terminated
- Graft Versus Host Disease
- +2 more
- muromonab-CD3
- +10 more
-
Seattle, Washington
- +1 more
Apr 17, 2017
Myocarditis Trial in Rochester (Muromonab-CD3, Cyclosporine)
Completed
- Myocarditis
- Muromonab-CD3
- Cyclosporine
-
Rochester, MinnesotaMayo Clinic Rochester
Mar 24, 2015
Solid Tumor Trial in Los Angeles (antibody therapy, biological therapy, muromonab-CD3)
Unknown status
- Unspecified Adult Solid Tumor, Protocol Specific
- antibody therapy
- +3 more
-
Los Angeles, CaliforniaSt. Vincent Medical Center - Los Angeles
Nov 5, 2013
Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial (biological, drug, procedure)
Terminated
- Chronic Myeloproliferative Disorders
- +5 more
- anti-thymocyte globulin
- +6 more
- (no location specified)
Dec 10, 2012
Myocarditis, Giant Cell Myocarditis Trial in Rochester (Cyclosporine, methylprednisolone, Muromonab-CD3)
Completed
- Myocarditis
- Giant Cell Myocarditis
- Cyclosporine
- +3 more
-
Rochester, MinnesotaMayo Clinic
Sep 8, 2010